Barbara K Finck's Net Worth
$140 Thousand
Who is Barbara K Finck?
Barbara K Finck does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Coherus BioSciences, Inc., Forte Biosciences, Inc., and Comera Life Sciences Holdings, Inc..
SEC CIK
Barbara K Finck's CIK is 0001242116
Past Insider Trading and Trends
2018 was Barbara K Finck's most active year for acquiring shares with 6 total transactions. Barbara K Finck's most active month to acquire stocks was the month of December. 2018 was Barbara K Finck's most active year for disposing of shares, totalling 10 transactions. Barbara K Finck's most active month to dispose stocks was the month of June. 2023 saw Barbara K Finck paying a total of $19,997.76 for 52,024 shares, this is the most they've acquired in one year. In 2018 Barbara K Finck cashed out on 14,080 shares for a total of $118,993.81, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Coherus BioSciences, Inc. (CHRS) Snapshot price: $1.26
Chief Medical OfficerBarbara K Finck owns 37,043 units of Common Stock, $0.0001 par value which is worth $46,674.18. In the year 2014 Barbara K Finck filed a total of 11 filings.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$10.00 | -$30,199.66 | 37.04K |
Scheduled
|
Sep 10
| ||
Form 4
|
—
|
0
|
$10.22 | -$30,980.75 | 37.04K |
Scheduled
|
Aug 13
| ||
Form 4
|
—
|
0
|
$8.22 | -$23,915.80 | 37.04K |
Scheduled
|
Jul 9 - Jul 10
| ||
Form 4
|
—
|
0
|
$8.21 | -$23,900.80 | 37.04K |
Scheduled
|
Jun 18
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +28.16% | 7.54K |
—
|
—
| 34.34K |
Dec 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 1
| |||
Form 4
|
∞
| 26.79K |
—
|
—
| 26.79K |
Nov 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Forte Biosciences, Inc. (FBRX) Snapshot price: $7.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 1
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 16
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Comera Life Sciences Holdings, Inc. (CMRA) Snapshot price: $0.0551
InvestorBarbara K Finck owns 23,033 units of Common Stock which is worth $1,269.12. In the year 2022 Barbara K Finck acquired a total of 13,512 shares in Comera Life Sciences Holdings, Inc. at a cost of $16,619.76.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
| +41.51% | 6.76K |
$1.23 | $8,309.88 | 23.03K |
Jan 4
| |||
Form 4
| +41.51% | 6.76K |
$1.23 | $8,309.88 | 23.03K |
Jan 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |